Revolutionary Dye-Free OCT/OCTA UWF Retinal Scan for Diabetic Patients | Dr. Mahmoud Hassan

Experiencing blurry vision? Discover the OCT/OCTA UWF technology for microscopic-level, dye-free examination of arteries and the retina in diabetic patients with Dr. Mahmoud Hassan at Mashreq Eye Center.

The Latest Dye-Free Digital Retinal Examination for Diabetic Patients: A Deeper Look at Eye Health

Diabetes is a chronic disease that affects multiple parts of the body, and perhaps the most prominent and dangerous of these effects is on the retina, known as diabetic retinopathy. This retinopathy can develop silently in its early stages, later leading to severe complications that may result in vision loss. The need for accurate and early retinal examinations has always posed a challenge for doctors, especially given the necessity of avoiding dyes that may cause allergies in some patients or require additional procedures. Fortunately, medical imaging technologies have witnessed tremendous development, and today we have a revolutionary technique that provides a microscopic view of the arteries and retina of the eye without the need for injecting any dyes. This technique is Optical Coherence Tomography (OCT) and Ultra-Widefield (UWF) Optical Coherence Tomography Angiography (OCTA).

What are Wide-Field (UWF) OCT and OCTA technologies?

Optical Coherence Tomography (OCT) can be thought of as the "X-ray" of the eye, using light to create high-resolution cross-sectional images of the retinal layers. Optical Coherence Tomography Angiography (OCTA) represents an evolution of this technology. It doesn't merely image the retinal layers but specifically focuses on blood flow within the tiny blood vessels of the retina and choroid, by capturing multiple images in the same location and analyzing subtle changes in red blood cell movement. When these techniques are combined with Ultra-Widefield (UWF) capability, they provide an unprecedented and comprehensive view of up to 80% of the retina, compared to traditional techniques that covered only about 30-40%. This wide field is crucial for diagnosing and monitoring diabetic retinopathy, as problems can begin or be present in the distant periphery of the retina that were not previously clearly visible.

Why is Dye-Free OCT/OCTA UWF a Revolution for Diabetic Patients?

Fluorescein Angiography (FFA) has long been the gold standard for evaluating blood vessels in diabetic retinopathy, revealing areas of leakage or occlusion in the vessels. However, as mentioned, it may not be suitable for everyone. This is where the importance of dye-free OCT/OCTA UWF technology stands out:

• Detailed Blood Vessel Imaging: OCTA can track minute blood vessels, identify areas of ischemia, and detect abnormal neovascularization, which are early and dangerous signs of diabetic retinopathy.

• Macular Edema Assessment: OCT precisely measures retinal thickness and identifies the presence of any subretinal or intraretinal fluid, a sign of macular edema, which is a leading cause of vision loss in diabetic patients.

• Early Detection of Changes: Thanks to the Ultra-Widefield (UWF), signs of diabetic retinopathy can be detected in the peripheral parts of the retina that may not show obvious symptoms initially, allowing for early therapeutic intervention.

• Safety and Comfort: Avoiding dye injection means reducing the risks of allergies or side effects, and the procedure is faster and more comfortable for the patient, especially for those with needle phobia or anxiety.

• Accurate Monitoring: High-resolution digital images allow for precise comparison of the condition over time, helping to evaluate the patient's response to treatment and adjust it if necessary.

Impact of Diabetic Retinopathy on Vision

Diabetic retinopathy can affect vision in several ways, including:

• Blurred Vision: Patients may feel their vision has become blurry and unclear, especially when looking at fine details.

• Floaters: Black spots or moving threads may appear in the field of vision, resulting from minor bleeding in the vitreous humor.

• Difficulty with Night Vision: The ability to see in low light may be affected.

• Peripheral Vision Loss: In advanced cases, the patient may begin to lose part of their visual field.

• Sudden Vision Loss: In severe cases, significant vitreous hemorrhage or retinal detachment may occur, leading to sudden and severe vision loss.

Early detection of these changes using technologies like the latest dye-free digital retinal examination for diabetic patients is key to preserving vision and preventing the progression to these advanced stages. Dr. Mahmoud Hassan, a key contributor at Al Mashreq Eye Center, is committed to using the latest diagnostic technologies to provide the best care for diabetic and other eye patients.

Latest Available Treatments for Diabetic Retinopathy

Once diabetic retinopathy is diagnosed, several treatment options are available aimed at slowing disease progression, reducing the risk of vision loss, and in some cases, improving vision. The choice of appropriate treatment depends on the stage and severity of the disease and includes options such as:

• Intravitreal Injections: Anti-vascular endothelial growth factor (Anti-VEGF) medications like Eylea or Vabysmo are very effective treatments for reducing macular edema and preventing the growth of new blood vessels. Cortisone injections may also be used in some cases.

• Laser Treatment: Argon laser can be used to destroy abnormal blood vessels or to treat areas of ischemia in the peripheral retina, helping to prevent hemorrhage or edema.

• Surgery (Vitrectomy): In advanced cases involving severe vitreous hemorrhage or retinal detachment, vitrectomy surgery may be necessary to remove blood or repair the retina.

The integration of advanced examinations such as OCT/OCTA UWF with modern treatment options represents a huge step towards controlling the ocular complications of diabetes. Dr. Mahmoud Hassan at Al Mashreq Eye Center is committed to providing the latest in ophthalmic technology to ensure the best outcomes for his patients.

For booking and inquiries: 01002310813

For more information on eye health and advanced technologies, you can follow Dr. Mahmoud Hassan's YouTube channel: .

Articles you might enjoy reading:

• Complications of Neglecting Diabetic Macular Edema: From Vision Impairment to Complete Fibrosis

• Intraocular Silicone Oil Lifespan and Risks of Permanent Retention

For appointments and inquiries: 01002310813

​📍 The Center's Prime Location and Currency Exchange Facilities:

​The center is located in Cairo, in the heart of Heliopolis, just a few kilometers from the airport, Sheraton Airport, Nasr City, First Settlement, and Fifth Settlement. It is also about 25 minutes from Downtown, Mohandessin, Gameat El Dewal St., Lebanon Square, and Abbasiya.

​Additionally, the center is surrounded by numerous banks and exchange offices to facilitate the conversion of various Arab and international currencies for the convenience of our international patients: Saudi Riyal, Jordanian Dinar, Sudanese Pound, Israeli Shekel for our patients from Palestine and Gaza Strip, Libyan Dinar, US Dollar, British Pound, and Euro...

https://drmahmoud-hassaan.com/en/articles/oct-and-octa-retinal-imaging